There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours. After-hours trades for Karuna Therapeutics Inc. (KRTX) shows that investor sentiment remained same, with the stock’s consolidated last price remained same to $188.70. The Karuna Therapeutics Inc. has recorded 5,396 volume in the after hours trading session. Yahoo Finance discussed the stock recently as it posted Karuna Therapeutics to Present at Upcoming Investor Conferences.
This NASDAQ-listed company operates within the Biotechnology industry segment, falling under the Healthcare sector. At the end of the last regular session, the stock closed at $188.70 and fluctuated between $190.77 as its day high and $185.84 as its day low. The current market capitalization of Karuna Therapeutics Inc. is $7.07B. A total of 0.19 million shares were traded on the day, compared to an average of 359.76K shares.
Insider trades can also provide insight into a stock’s future direction. During the recent three months, KRTX has seen 11 BUY and 13 SELL insider trades, representing the acquisition of 43,575 and the disposition of 429,870 shares. Over the last 12 months, there were 47 BUYs and 51 SELLs from insiders. Insiders purchased 284,315 shares during that period but sold 916,414.
In the most recent transaction, Ignelzi Troy A. sold 1,500 shares of KRTX for 175.12 per share on Aug 22. After the transaction, the Chief Financial Officer now owns 30,487 company shares. In a previous transaction on Aug 08, Brannan Stephen K. sold 5,000 shares at 180.40 per share. KRTX shares that Chief Medical Officer owns now total 26,150.
Among the insiders who sold shares, JONAS JEFFREY M disposed of 13,810 shares on Aug 01 at a per-share price of $195.81. This resulted in the Director holding 990 shares of KRTX after the transaction. In another insider transaction, JONAS JEFFREY M sold 13,810 shares at $216.42 per share on Jul 03. Company shares held by the Director now total 990.
Even though price targets are rarely accurate, they do tend to exert some kind of influence from time to time and are often considered important by markets. According to analysts who have offered 12-month price targets for KRTX in the last 3 months, the mean price target is $273.61 with high estimates of $332.00 and low estimates of $197.00. In terms of 52-week highs and lows, KRTX has a high of $263.88 and a low of $159.73.
As of this writing, KRTX has an earnings estimate of -$2.76 per share for the current quarter. EPS was calculated based on a consensus of 18 estimates, with a high estimate of -$2 per share and a lower estimate of -$3.33. The company reported an EPS of -$2.8 in the last quarter, which was -1.80% lower than expectations of -$2.75.
Balance Sheet Annually/Quarterly
In a balance sheet, you can see what assets and liabilities the company has, as well as how much equity investors have invested. These figures can be used to calculate a company’s financial ratios to give investors a better idea of its prospects.
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for KRTX is Buy with a score of 4.72.